Clinical Trials on Group A- 23 Implant Using Switch Platform -SPK Abutment. in Ireland
Total 0 results
Nothing found
Sponsors and Collaborators
- JMI Laboratories
- Prof. Jacques SCHRENZEL
- Dr. Praveen B.H
- The Fred Hollows Foundation, Australia
- Physip S.A
- Janssen (China) Research & Development Center
- Markham Stouffville Hospital
- Hospital Samaritano Paulista
- Advanced Life Solutions
- Pedro Gamito
- Stannah Stairlifts
- Custom Pharmaceuticals Limited
- Fogarty International Center of the National Institute of Health
- IN-JET APS
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Hazelden Betty Ford Foundation
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- UZ Leuven, campus Pellenberg (Belgium)
- Nestlé Health Science Belgium
- Familien Hede Nielsens Fond
- View Full List
Medical Conditions
- Fetus or Neonate Affected by External Version Before Labor
- Skull Base Neoplasms
- Gullian Barre Syndrome
- Ewing's Family Tumors
- Endocarditis Infective
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Predictors of Atrial Fibrillation Recurrences
- Pulmonary Adenocarcinoma
- Epidemic Hemorrhagic Fever
- Childhood Langerhans Cell Histiocytosis
- Fracture Dislocation of Cervical Spine
- Chlamydophila Infections
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Multisystem Proteinopathy
- Tay-Sachs Disease Ganglioside
- Psoriasis, Arthritic
- Painless Hysteroscopy
- Closure; Foramen Ovale
- Spine Surgeries
- View Full List
Drug Interventions
- Qingkailing injection 40 ml
- Vehicle
- Glimepiride
- Semapimod
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Neihulizumab
- Cereport
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- High dose pantoprazole infusion
- Palliative care group first-line scheme
- Esomeprazole 40mg before
- Adriamycin
- Redifferentiation with retinoid acid
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- EFV +TVA
- Azelastine hydrochloride (BAYR9258)
- Estradiol+Drospirenone
- Adapalene Gel 0.3%
- Chemotherapeutic Agent
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Belarus
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Gabon
- Contract Research Organizations in Gambia
- Contract Research Organizations in Jordan
- Contract Research Organizations in Malawi
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Togo
- Contract Research Organizations in United Arab Emirates
- CRO list by country